Barrx Medical

Endorse Company
The Barrx RF ablation system is designed to remove the Barrett’s esophagus epithelium in a short endoscopic procedure that patients tolerate well. Recognizing the need to reduce risks of progression to cancer, many physicians searched for therapies that would replace the “watch and wait” Barrett’s esophagus management protocol with a “diagnose and treat” standard of care. The Barrx™ RF ablation system offered by Covidien GI Solutions provides a uniform and controlled ablative therapy at a consistent depth. It can remove the layer of diseased tissue while sparing healthy underlying tissue. This allows regrowth of new, healthy tissue within eight weeks.